Search Results 141-150 of 17204 for ulcerative colitis
... IBD. Aug. 16, 2019. Approved in 1998 for use in treating Crohn's disease and subsequently in 2005 for treating ulcerative colitis, anti-tumor necrosis factor ...
... ulcerative colitis (UC) patients undergoing colectomy with eventual ileal pouch anal anastomosis (IPAA) compared to standard of care for weight loss.
Amanda Johnson, M.D.. Gastroenterology. Mayo Clinic. “Ulcerative colitis really tends to only involve the colon and be more of a superficial type inflammation.
There are two main types of IBD: Crohn's disease and ulcerative colitis. Victor Chedid, M.D.. Gastroenterology. Mayo Clinic. "Ulcerative colitis only impacts ...
The purpose of this study is to assess the long-term safety of vedolizumab versus other biologic agents in participants with Ulcerative Colitis or Crohn's ...
Dorin T. Colibaseanu, M.D.. Colon and Rectal Surgeon. Jacksonville, FL. Areas of focus: Neuroendocrine tumor, Ulcerative colitis, Inflammatory bowel disease ...
The purpose of this study is to evaluate the efficacy of SHP647 as maintenance therapy in participants with moderate to severe ulcerative colitis (UC) who ...
A Study of JNJ-77242113 in Participants With Moderately to Severely Active Ulcerative Colitis (ANTHEM-UC). Print details. Share; Facebook · Twitter. Overview ...
Ulcerative colitis · Ulcerative colitis flare-ups: 5 tips to manage them · Vesicoureteral reflux · How irritable bowel syndrome affects you · Vitamin deficiency ...
Olsalazine is used in patients who have had ulcerative colitis to prevent the condition from occurring again. It works inside the bowel by helping to reduce ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your GivingTuesday gift can go 2X as far.